Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results

Go back to Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
(NASDAQ: DSGN) Delayed: 15.53 +0.39 (2.58%)
Previous Close $15.14    52 Week High
Open $15.25    52 Week Low
Day High $15.75    P/E N/A 
Day Low $15.17    EPS
Volume 769,667